Restless Legs Syndrome

Neurologic Clinics

Volumn 27, Issue 3, 2009, Pages 779-799

  Ondo, William G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine; Genetics; Iron; Restless legs syndrome; Treatment

Indexed keywords

APOMORPHINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BROMOCRIPTINE; CABERGOLINE; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; GABAPENTIN ENACARBIL; HYDROCODONE; IRON; IRON DEXTRAN; LEVODOPA; LISURIDE; MAGNESIUM; METHADONE; NARCOTIC ANALGESIC AGENT; PERGOLIDE; PLACEBO; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE; SOLZIRA; TRAMADOL; UNCLASSIFIED DRUG;

CHILDHOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; ELECTROMYOGRAM; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; NERVE CONDUCTION; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SECONDARY RESTLESS LEGS SYNDROME; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT;

ANIMALS; BENZODIAZEPINES; CHILD; CONTINENTAL POPULATION GROUPS; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOVEMENT; PERIODICITY; PREVALENCE; RESTLESS LEGS SYNDROME; SLEEP;

EID: 67449098375     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2009.04.007     Document Type: Review

References (205)

1. Allen R.P., Picchietti D., Hening W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 2 (2003) 101-119
2. Hening W.A., Allen R.P., Washburn M., et al. Validation of the Hopkins telephone diagnostic interview for restless legs syndrome. Sleep Med 9 3 (2008) 283-289
3. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 2 (2003) 121-132
4. Atkinson M.J., Allen R.P., DuChane J., et al. Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation. Qual Life Res 13 3 (2004) 679-693
5. Ondo W., and Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 47 6 (1996) 1435-1441
6. Ancoli-Israel S., Kripke D.F., Klauber M.R., et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 14 6 (1991) 496-500
7. Mosko S.S., Dickel M.J., Paul T., et al. Sleep apnea and sleep-related periodic leg movements in community resident seniors. J Am Geriatr Soc 36 6 (1988) 502-508
8. Roehrs T., Zorick F., Sicklesteel J., et al. Age-related sleep-wake disorders at a sleep disorder center. J Am Geriatr Soc 31 6 (1983) 364-370
9. Bixler E.O., Kales A., and Vela-Bueno A. Nocturnal myoclonus and nocturnal myoclonic activity in a normal population. Res Commun Chem Pathol Pharmacol 36 (1982) 129-140
10. Montplaisir J., Boucher S., Poirier G., et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12 1 (1997) 61-65
11. Coleman R.M., Miles L.E., Guilleminault C.C., et al. Sleep-wake disorders in the elderly: polysomnographic analysis. J Am Geriatr Soc 29 7 (1981) 289-296
12. Lugaresi E., Coccagna G., Mantovani M., et al. Some periodic phenomena arising during drowsiness and sleep in man. Electroencephalogr Clin Neurophysiol 32 6 (1972) 701-705
13. Montplaisir J., Boucher S., Gosselin A., et al. Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-DOPA. Sleep 19 3 (1996) 196-199
14. Wiegand M., Schacht-Muller W., and Starke C. [Psychophysiologic insomnia and periodic leg movements in sleep syndrome]. Wien Med Wochenschr 145 17-18 (1995) 527-528 [in German]
15. Simakajornboon N., Kheirandish-Gozal L., and Gozal D. Diagnosis and management of restless legs syndrome in children. Sleep Med Rev 13 2 (2009) 149-156
16. Ekbom K.A. Growing pains and restless legs. Acta Paediatr Scand 64 2 (1975) 264-266
17. Rajaram S.S., Walters A.S., England S.J., et al. Some children with growing pains may actually have restless legs syndrome. Sleep 27 4 (2004) 767-773
18. Kotagal S., and Silber M.H. Childhood-onset restless legs syndrome. Ann Neurol 56 6 (2004) 803-807
19. Chervin R.D., Archbold K.H., Dillon J.E., et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep 25 2 (2002) 213-218
20. Picchietti D.L., England S.J., Walters A.S., et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 13 12 (1998) 588-594
21. Chervin R.D., Dillon J.E., Archbold K.H., et al. Conduct problems and symptoms of sleep disorders in children. J Am Acad Child Adolesc Psychiatry 42 2 (2003) 201-208
22. Konofal E., Lecendreux M., Bouvard M.P., et al. High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci 55 2 (2001) 97-103
23. Picchietti D.L., Underwood D.J., Farris W.A., et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 14 6 (1999) 1000-1007
24. Picchietti D.L., and Walters A.S. Moderate to severe periodic limb movement disorder in childhood and adolescence. Sleep 22 3 (1999) 297-300
25. Walters A.S., Mandelbaum D.E., Lewin D.S., et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol 22 3 (2000) 182-186
26. Sachdev P., and Longragan C. The present status of akathisia. J Nerv Ment Dis 179 7 (1991) 381-391
27. Dressler D., Thompson P.D., Gledhill R.F., et al. The syndrome of painful legs and moving toes. Mov Disord 9 1 (1994) 13-21
28. Ekbom K.A. Restless legs syndrome. Neurology 10 (1960) 868-873
29. Lavigne G.J., and Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17 8 (1994) 739-743
30. Oboler S.K., Prochazka A.V., and Meyer T.J. Leg symptoms in outpatient veterans. West J Med 155 3 (1991) 256-259
31. Phillips B., Young T., Finn L., et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160 14 (2000) 2137-2141
32. Hening W., Walters A.S., Allen R.P., et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5 3 (2004) 237-246
33. Ondo W.G., Vuong K.D., and Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 55 9 (2000) 1404-1406
34. Xiong L., Jang K., Montplaisir J., et al. Canadian restless legs syndrome twin study. Neurology 68 19 (2007) 1631-1633
35. Winkelmann J., Muller-Myhsok B., Wittchen H.U., et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52 3 (2002) 297-302
36. Earley C.J., Connor J.R., Beard J.L., et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54 8 (2000) 1698-1700
37. Allen R.P., Barker P.B., Wehrl F., et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56 2 (2001) 263-265
38. Astrakas L.G., Konitsiotis S., Margariti P., et al. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 71 12 (2008) 911-916
39. Schmidauer C., Sojer M., Stocckner H., et al. Brain parenchyma sonography differentiates RLS patients from normal controls and patients with Parkinson's disease. Mov Disord 20 Suppl 10 (2005) S43 [abstract]
40. Godau J., Klose U., Di Santo A., et al. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord 23 8 (2008) 1184-1187
41. Connor J.R., Wang X.S., Patton S.M., et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 62 9 (2004) 1563-1567
42. Wang X., Wiesinger J., Beard J., et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci 220 1-2 (2004) 59-66
43. Pittock S.J., Parrett T., Adler C.H., et al. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord 19 6 (2004) 695-699
44. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61 3 (2003) 304-309
45. Garcia-Borreguero D., Larrosa O., Granizo J.J., et al. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep 27 4 (2004) 669-673
46. Staedt J., Stoppe G., Kogler A., et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 245 1 (1995) 8-10
47. Trenkwalder C., Walters A.S., Hening W.A., et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 14 1 (1999) 141-145
48. Turjanski N., Lees A.J., and Brooks D.J. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52 5 (1999) 932-937
49. Tribl G.G., Asenbaum S., Happe S., et al. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nucl Med Commun 25 1 (2004) 55-60
50. Allen R.P., Connor J.R., Hyland K., et al. Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis. Sleep Med 10 1 (2009) 123-128
51. Nelson C., Erikson K., Pinero D.J., et al. In vivo dopamine metabolism is altered in iron-deficient anemic rats. J Nutr 127 12 (1997) 2282-2288
52. Stiasny-Kolster K., Moller J.C., Zschocke J., et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 19 2 (2004) 192-196
53. Earley C.J., Hyland K., and Allen R.P. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord 16 1 (2001) 144-149
54. Ben-Shachar D., Finberg J.P., and Youdim M.B. Effect of iron chelators on dopamine D2 receptors. J Neurochem 45 4 (1985) 999-1005
55. Ashkenazi R., Ben-Shachar D., and Youdim M.B. Nutritional iron and dopamine binding sites in the rat brain. Pharmacol Biochem Behav 17 Suppl 1 (1982) 43-47
56. Zhao H., Zhu W., Pan T., et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 85 5 (2007) 1065-1076
57. Ye Z., and Connor J.R. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res 28 8 (2000) 1802-1807
58. Jeng C.J., McCarroll S.A., Martin T.F., et al. Thy-1 is a component common to multiple populations of synaptic vesicles. J Cell Biol 140 3 (1998) 685-698
59. Shults C.W., and Kimber T.A. Thy-1 immunoreactivity distinguishes patches/striosomes from matrix in the early postnatal striatum of the rat. Brain Res Dev Brain Res 75 1 (1993) 136-140
60. Lee S.J., Kim J.S., Song I.U., et al. Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord 24 1 (2009) 77-84
61. Ondo W.G., He Y., Rajasekaran S., et al. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 15 1 (2000) 154-158
62. Qu S., Le W., Zhang X., et al. Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 66 5 (2007) 383-388
63. Walters A.S., Ondo W.G., Zhu W., et al. Does the endogenous opiate system play a role in the Restless Legs Syndrome?: A pilot post-mortem study. J Neurol Sci 279 1-2 (2009) 62-65
64. Stiasny-Kolster K., Magerl W., Oertel W.H., et al. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 127 Pt 4 (2004) 773-782
65. Manconi M., Rocca M.A., Ferini-Strambi L., et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 14 1 (2008) 86-93
66. Abele M., Burk K., Laccone F., et al. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol 248 4 (2001) 311-314
67. Schols L., Haan J., Riess O., et al. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?. Neurology 51 6 (1998) 1603-1607
68. van Alfen N., Sinke R.J., Zwarts M.J., et al. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 49 6 (2001) 805-807
69. Yunus M.B., and Aldag J.C. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 312 7042 (1996) 1339
70. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am 28 2 (2002) 353-365
71. Stehlik R., Arvidsson L., and Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 61 2 (2009) 107-111
72. Reynolds G., Blake D.R., Pall H.S., et al. Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) 292 6521 (1986) 659-660
73. Salih A.M., Gray R.E., Mills K.R., et al. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 33 1 (1994) 60-63
74. Gudbjornsson B., Broman J.E., Hetta J., et al. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol 32 12 (1993) 1072-1076
75. Taylor-Gjevre R.M., Gjevre J.A., Skomro R., et al. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 15 1 (2009) 12-15
76. Gemignani F., Marbini A., Di Giovanni G., et al. Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 52 5 (1999) 1064-1066
77. Gemignani F., Marbini A., Di Giovanni G., et al. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome. J Neurol Sci 152 2 (1997) 218-223
78. Frankel B.L., Patten B.M., and Gillin J.C. Restless legs syndrome. Sleep-electroencephalographic and neurologic findings. JAMA 230 9 (1974) 1302-1303
79. Iannaccone S., Zucconi M., Marchettini P., et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 10 1 (1995) 2-9
80. Polydefkis M., Allen R.P., Hauer P., et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 55 8 (2000) 1115-1121
81. Salvi F., Montagna P., Plasmati R., et al. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry 53 6 (1990) 522-525
82. O'Hare J.A., Abuaisha F., and Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 163 3 (1994) 132-135
83. Rutkove S.B., Matheson J.K., and Logigian E.L. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 19 5 (1996) 670-672
84. Harriman D.G., Taverner D., and Woolf A.L. Ekbom's syndrome and burning paresthesiae: a biopsy study by vital staining and electron microscopy of the intramuscular innervation with a note on age changes in motor nerve endings. Brain 93 (1970) 393-406
85. Gorman C.A., Dyck P.J., and Pearson J.S. Symptom of restless legs. Arch Intern Med 115 (1965) 155-160
86. Walters A.S., Wagner M., and Hening W.A. Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy. [letter]. Sleep 19 10 (1996) 825-826
87. Bara-Jimenez W., Aksu M., Graham B., et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 54 8 (2000) 1609-1616
88. de Mello M.T., Lauro F.A., Silva A.C., et al. Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. Spinal Cord 34 5 (1996) 294-296
89. Hartmann M., Pfister R., and Pfadenhauer K. Restless legs syndrome associated with spinal cord lesions. J Neurol Neurosurg Psychiatry 66 5 (1999) 688-689
90. Lee M.S., Choi Y.C., Lee S.H., et al. Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord 11 6 (1996) 719-722
91. Brown L.K., Heffner J.E., and Obbens E.A. Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen. Sleep 23 5 (2000) 591-594
92. Bruno R.L. Abnormal movements in sleep as a post-polio sequelae. Am J Phys Med Rehabil 77 4 (1998) 339-343
93. Hemmer B., Riemann D., Glocker F.X., et al. Restless legs syndrome after a borrelia-induced myelitis. Mov Disord 10 4 (1995) 521-522
94. Winkelmann J., Wetter T.C., Trenkwalder C., et al. Periodic limb movements in syringomyelia and syringobulbia. Mov Disord 15 4 (2000) 752-753
95. Hogl B., Frauscher B., Seppi K., et al. Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology 59 11 (2002) 1705-1707
96. Moorthy S.S., and Dierdorf S.F. Restless legs during recovery from spinal anesthesia. Anesth Analg 70 3 (1990) 337
97. Bhatia M., and Bhowmik D. Restless legs syndrome in maintenance haemodialysis patients. Nephrol Dial Transplant 18 1 (2003) 217
98. Collado-Seidel V., Kohnen R., Samtleben W., et al. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31 2 (1998) 324-328
99. Fukunishi I., Kitaoka T., Shirai T., et al. Facial paresthesias resembling restless legs syndrome in a patient on hemodialysis. Nephron 79 4 (1998) 485
100. Holley J.L., Nespor S., and Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans 37 3 (1991) M456-M457
101. Hui D.S., Wong T.Y., Ko F.W., et al. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 36 4 (2000) 783-788 [computer file]
102. Hui D.S., Wong T.Y., Li T.S., et al. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit 8 5 (2002) CR331-CR336
103. Huiqi Q., Shan L., and Mingcai Q. Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions. Nephron 86 4 (2000) 540
104. Parker K.P. Sleep disturbances in dialysis patients. Sleep Med Rev 7 2 (2003) 131-143
105. Pieta J., Millar T., Zacharias J., et al. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep 21 6 (1998) 617-622
106. Roger S.D., Harris D.C., and Stewart J.H. Possible relation between restless legs and anaemia in renal dialysis patients. [letter]. Lancet 337 8756 (1991) 1551
107. Sabbatini M., Minale B., Crispo A., et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant 17 5 (2002) 852-856
108. Stepanski E., Faber M., Zorick F., et al. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 6 2 (1995) 192-197
109. Walker S.L., Fine A., and Kryger M.H. L-DOPA/carbidopa for nocturnal movement disorders in uremia. Sleep 19 3 (1996) 214-218
110. Virga G., Mastrosimone S., Amici G., et al. Symptoms in hemodialysis patients and their relationship with biochemical and demographic parameters. Int J Artif Organs 21 12 (1998) 788-793
111. Wetter T.C., Stiasny K., Kohnen R., et al. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord 13 5 (1998) 820-824
112. Winkelman J.W., Chertow G.M., and Lazarus J.M. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 28 3 (1996) 372-378
113. Read D.J., Feest T.G., and Nassim M.A. Clonazepam: effective treatment for restless legs syndrome in uraemia. Br Med J (Clin Res Ed) 283 6296 (1981) 885-886
114. Tanaka K., Morimoto N., Tashiro N., et al. The features of psychological problems and their significance in patients on hemodialysis-with reference to social and somatic factors. Clin Nephrol 51 3 (1999) 161-176
115. Enomoto M., Inoue Y., Namba K., et al. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients. Mov Disord 23 6 (2008) 811-816 [quiz 926]
116. Benz R.L., Pressman M.R., and Peterson D.D. Periodic limb movements of sleep index (PLMSI): a sensitive predictor of mortality in dialysis patients. JASN 5 (1994) 433
117. Molnar M.Z., Szentkiralyi A., Lindner A., et al. Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis 50 5 (2007) 813-820
118. Yasuda T., Nishimura A., Katsuki Y., et al. Restless legs syndrome treated successfully by kidney transplantation-a case report. Clin Transpl (1986) 138
119. Winkelmann J., Stautner A., Samtleben W., et al. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 17 5 (2002) 1072-1076
120. Azar S.A., Hatefi R., and Talebi M. Evaluation of effect of renal transplantation in treatment of restless legs syndrome. Transplant Proc 39 4 (2007) 1132-1133
121. Ondo W.G., Vuong K.D., and Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59 3 (2002) 421-424
122. O'Keeffe S.T., Gavin K., and Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 23 3 (1994) 200-203
123. Silber M.H., and Richardson J.W. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78 1 (2003) 52-54
124. Sun E.R., Chen C.A., Ho G., et al. Iron and the restless legs syndrome. Sleep 21 4 (1998) 371-377
125. Aul E.A., Davis B.J., and Rodnitzky R.L. The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology 51 3 (1998) 912
126. Ulfberg J., and Nystrom B. Restless legs syndrome in blood donors. Sleep Med 5 2 (2004) 115-118
127. Ondo W., Tan E.K., and Mansoor J. Rheumatologic serologies in secondary restless legs syndrome. Mov Disord 15 2 (2000) 321-323
128. Earley C.J., Allen R.P., Beard J.L., et al. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 62 5 (2000) 623-628
129. Goodman J.D., Brodie C., and Ayida G.A. Restless leg syndrome in pregnancy. BMJ 297 6656 (1988) 1101-1102
130. Botez M.I., and Lambert B. Folate deficiency and restless-legs syndrome in pregnancy. [letter]. N Engl J Med 297 12 (1977) 670
131. Manconi M., Govoni V., DeVito, et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 5 3 (2004) 305-308
132. Lee K.A., Zaffke M.E., and Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 10 4 (2001) 335-341
133. Tunc T., Karadag Y.S., Dogulu F., et al. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 22 5 (2007) 627-631
134. Ruottinen H.M., Partinen M., Hublin C., et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 54 2 (2000) 502-504
135. Wetter T.C., Collado-Seidel V., Pollmacher T., et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23 3 (2000) 361-367
136. Gomez-Esteban J.C., Zarranz J.J., Tijero B., et al. Restless legs syndrome in Parkinson's disease. Mov Disord 22 13 (2007) 1912-1916
137. Driver-Dunckley E., Evidente V.G., Adler C.H., et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 21 8 (2006) 1287-1289
138. Chaudhuri K.R., Martinez-Martin P., Schapira A.H., et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 21 7 (2006) 916-923
139. Braga-Neto P., da Silva Jr. F.P., Sueli Monte F., et al. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 217 1 (2004) 41-45
140. Krishnan P.R., Bhatia M., and Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 18 2 (2003) 181-185
141. Tan E.K., Lum S.Y., and Wong M.C. Restless legs syndrome in Parkinson's disease. J Neurol Sci 196 1-2 (2002) 33-36
142. Ondo W.G., and Lai D. Association between restless legs syndrome and essential tremor. Mov Disord 21 4 (2006) 515-518
143. Trenkwalder C., Garcia-Borreguero D., Montagna P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 1 (2004) 92-97
144. Walters A.S., Ondo W.G., Dreykluft T., et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19 12 (2004) 1414-1423
145. Bogan R., Connolly G., and Rederich G. Ropinirole is effective, well tolerated treatment for moderate-to-severe RLS: results of a U.S. study. Mov Disord 20 Suppl 10 (2005) S61
146. Oertel W., and Stiasney-Kolster K. Pramipexole is effective in the treatment of restless legs syndrome (RLS): results of a 6 week, multi-centre, double, and placebo controlled study. Mov Disord 20 Suppl 10 (2005) S58
147. Trenkwalder C., Stiasny-Kolster K., Kupsch A., et al. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 21 9 (2006) 1404-1410
148. Partinen M., Hirvonen K., Jama L., et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study-the PRELUDE study. Sleep Med 7 5 (2006) 407-417
149. Trenkwalder C., Benes H., Poewe W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 7 7 (2008) 595-604
150. Oertel W.H., Benes H., Garcia-Borreguero D., et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 9 3 (2008) 228-239
151. Earley C.J., Yaffee J.B., and Allen R.P. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 51 6 (1998) 1599-1602
152. Staedt J., Wassmuth F., Ziemann U., et al. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa. J Neural Transm (Budapest) 104 4-5 (1997) 461-468
153. Trenkwalder C., Brandenburg U., Hundemer H., et al. A randomized long-term placebo controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology 56 Suppl 3 (2001) A5
154. Wetter T.C., Stiasny K., Winkelmann J., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52 5 (1999) 944-950
155. Walters A.S., Hening W.A., Kavey N., et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24 3 (1988) 455-458
156. Reuter I., Ellis C.M., and Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 100 3 (1999) 163-167
157. Happe S., and Trenkwalder C. Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs 18 1 (2004) 27-36
158. Benes H. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome. Sleep Med 7 1 (2006) 31-35
159. Benes H., Kurella B., Kummer J., et al. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial. Sleep 22 8 (1999) 1073-1081
160. Brodeur C., Montplaisir J., Godbout R., et al. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 38 12 (1988) 1845-1848
161. Collado-Seidel V., Kazenwadel J., Wetter T.C., et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 52 2 (1999) 285-290
162. Kaplan P.W., Allen R.P., Buchholz D.W., et al. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 16 8 (1993) 717-723
163. Saletu M., Anderer P., Hogl B., et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm 110 6 (2003) 611-626
164. Trenkwalder C., Benes H., Grote L., et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Mov Disord 22 5 (2007) 696-703
165. Pellecchia M.T., Vitale C., Sabatini M., et al. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Clin Neuropharmacol 27 4 (2004) 178-181
166. Allen R.P., and Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19 3 (1996) 205-213
167. Stiasny K., Wetter T.C., Winkelmann J., et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 56 10 (2001) 1399-1402
168. Montplaisir J., Denesle R., and Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 7 Suppl 1 (2000) 27-31
169. Garcia-Borreguero D., Kohnen R., Hogl B., et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med 8 5 (2007) 455-463
170. Walters A.S., Winkelmann J., Trenkwalder C., et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 16 6 (2001) 1105-1109
171. Walters A.S., Wagner M.L., Hening W.A., et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16 4 (1993) 327-332
172. Ondo W.G. Methadone for refractory restless legs syndrome. Mov Disord 20 3 (2005) 345-348
173. Merlino G., Serafini A., Young J.J., et al. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome. Curr Opin Investig Drugs 10 1 (2009) 91-102
174. O'Keeffe S.T., Noel J., and Lavan J.N. Restless legs syndrome in the elderly. Postgrad Med J 69 815 (1993) 701-703
175. Davis B.J., Rajput A., Rajput M.L., et al. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 43 2 (2000) 70-75
176. Earley C.J., Heckler D., and Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5 3 (2004) 231-235
177. Sloand J.A., Shelly M.A., Feigin A., et al. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 43 4 (2004) 663-670
178. Lettieri C.J., and Eliasson A.H. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest 135 1 (2009) 74-80
179. Nahab F.B., Peckham E.L., and Hallett M. Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome. Neurology 71 12 (2008) 950-951
180. Ondo W. VIM deep brain stimulation does not improve pre-existing restless legs syndrome in patients with essential tremor. Parkinsonism Relat Disord 12 2 (2006) 113-114
181. Tison F., Crochard A., Leger D., et al. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 65 2 (2005) 239-246
182. Garbarino S., De Carli F., Nobili L., et al. Sleepiness and sleep disorders in shift workers: a study on a group of italian police officers. Sleep 25 6 (2002) 648-653
183. Ohayon M.M., and Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53 1 (2002) 547-554
184. Berger K., Luedemann J., Trenkwalder C., et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164 2 (2004) 196-202
185. Rothdach A.J., Trenkwalder C., Haberstock J., et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 54 5 (2000) 1064-1068
186. Nichols D.A., Allen R.P., Grauke J.H., et al. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 163 19 (2003) 2323-2329
187. Ulfberg J., Nystrom B., Carter N., et al. Restless Legs Syndrome among working-aged women. Eur Neurol 46 1 (2001) 17-19
188. Ulfberg J., Nystrom B., Carter N., et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 16 6 (2001) 1159-1163
189. Lavigne G.L., Lobbezoo F., Rompre P.H., et al. Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep 20 4 (1997) 290-293
190. Cho Y.W., Shin W.C., Yun C.H., et al. Epidemiology of restless legs syndrome in Korean adults. Sleep 31 2 (2008) 219-223
191. Sevim S., Dogu O., Camdeviren H., et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 61 11 (2003) 1562-1569
192. Tan E.K., Seah A., See S.J., et al. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 16 3 (2001) 577-579
193. Kageyama T., Kabuto M., Nitta H., et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci 54 3 (2000) 296-298
194. Stefansson H., Rye D.B., Hicks A., et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357 7 (2007) 639-647
195. Winkelmann J., Schormair B., Lichtner P., et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39 8 (2007) 1000-1006
196. Schormair B., Kemlink D., Roeske D., et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40 8 (2008) 946-948
197. Desautels A., Turecki G., Montplaisir J., et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 59 2 (2002) 215-219
198. Winkelmann J., Lichtner P., Schormair B., et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 23 3 (2008) 350-358
199. Desautels A., Turecki G., Montplaisir J., et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 62 4 (2005) 591-596
200. Bonati M.T., Ferini-Strambi L., Aridon P., et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 126 Pt 6 (2003) 1485-1492
201. Chen S., Ondo W.G., Rao S., et al. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 74 5 (2004) 876-885
202. Pichler I., Marroni F., Volpato C.B., et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 79 4 (2006) 716-723
203. Levchenko A., Provost S., Montplaisir J.Y., et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 67 5 (2006) 900-901
204. Lohmann-Hedrich K., Neumann A., Kleensang A., et al. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci?. Neurology 70 9 (2008) 686-694
205. Levchenko A., Montplaisir J.Y., Asselin G., et al. Autosomal-dominant locus for Restless Legs Syndrome in French-Canadians on chromosome 16p12.1. Mov Disord 24 1 (2009) 40-50